Publication | Closed Access

Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

Gastrointestinal OncologyCetuximab ContinuationMedicinePathologyColorectal CancerMetastatic Colorectal CancerCancer TreatmentFirst ProgressionOncologyRadiation OncologyMolecular Oncology